Index Every US public charity, on the record

Alzheimers Disease Research Foundation

Wellesley Hills, Massachusetts
EIN 52-2396428Grantmaking public charityLatest return year ending December 2025Its profile as a public charity

Applications

Applications

Schedule I of Form 990 lists the grants made, not how to apply, so this return does not say whether Alzheimers Disease Research Foundation accepts applications.

From its returns

What it gave

Alzheimers Disease Research Foundation paid $37,323,497 in grants in the year ending December 2025.

Grants paid
$37,323,497
Year ending December 2025
Grants listed
161
To organizations, on that return
Typical grant
$201,250
Half fall between $181,004 and $230,000
Year endingGrants paidGrants listed
December 2025$37,323,497161
December 2024$28,828,950106

From Schedule I of its Form 990 returns for the years ending December 2024 to December 2025.

Focus and places

What it funds, and where

From the 267 grants listed on its returns for the years ending December 2024 to December 2025. A grant counts toward a focus only when it is linked to the charity that received it: 82 of 267 are.

Focus, by share of linked grant dollars

  • Health care81%
  • Medical research8%
  • Animals4%
  • Science3%
  • Education2%

Where it gave, by number of grants

  • Massachusetts79
  • New York39
  • California39
  • Missouri35
  • Texas11
  • Maryland8
  • Florida8
  • Illinois7
  • Virginia7
  • North Carolina6
  • Pennsylvania5
  • Michigan5

From Schedule I of its Form 990 returns for the years ending December 2024 to December 2025.

Grants

Recent grants to organizations

The largest grants on its latest returns, as filed. A name links to the charity’s profile when the match is certain.

RecipientYear endingAmountPurpose
Mass General Brigham IncorporatedSomerville, MassachusettsDecember 2025$1,955,000THE CUREALZ ALZHEIMER'S GENOME PROJECT
Mass General Brigham IncorporatedSomerville, MassachusettsDecember 2025$575,000APOE4 ACCELERATES CD8 EXHAUSTION VIA GLUCOCORTICOID SIGNALING IN ALZHEIMER'S FEMALE CARRIERS
Mass General Brigham IncorporatedSomerville, MassachusettsDecember 2025$431,250A NEW MODEL OF MICROGLIA GENETIC PERTURBATION IN VIVO TO SCREEN ALL RISK FACTORS ASSOCIATED WITH ALZHEIMER'S DISEASE
UNIVERSITY OF MICHIGANAnn Arbor, MichiganDecember 2025$402,500NON-INVASIVE MODULATION OF MICROGLIA GENE EXPRESSION USING PERIPHERALLY ADMINISTERED ANTIBODY CONJUGATES
WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITYNew York, New YorkDecember 2025$402,500SEX-BIASED TLR7 SIGNALING IN DEMYELINATION AND ITS INHIBITION BY SMALL MOLECULES
UNIVERSITY OF CALIFORNIA IRVINEIrvine, CaliforniaDecember 2025$402,492PROTEOMIC SIGNATURES OF CEREBROVASCULAR NEUROPATHOLOGY IN DOWN SYNDROME WITH ALZHEIMER DISEASE
UNIVERSITY OF MICHIGANAnn Arbor, MichiganDecember 2025$398,521UTILIZING HETEROGENEOUS MOUSE MODELS TO DISCOVER MECHANISMS UNDERLYING CALORIC RESTRICTION (CR) ON COGNITIVE OUTCOMES
WASHINGTON UNIVERSITY IN ST LOUISSt Louis, MissouriDecember 2025$345,000APOE CONSORTIUM: INVESTIGATING POTENTIAL CELL AUTONOMOUS NEUROPROTECTION OF APOE PROTECTIVE VARIANTS
WASHINGTON UNIVERSITY IN ST LOUISSt Louis, MissouriDecember 2025$345,000BAC: IDENTIFYING AGE-RELATED PROTEOMIC CHANGES THAT PREDICT FUTURE ONSET OF AMYLOID-BETA AGGREGATION IN ALZHEIMER'S DISEASE
WASHINGTON UNIVERSITY IN ST LOUISSt Louis, MissouriDecember 2025$345,000BEE: MENINGEAL MAST CELL CONTROL OF CSF DYNAMICS IN HOMEOSTASIS AND ALZHEIMER'S DISEASE
BOSTON CHILDREN'S HOSPITALBoston, MassachusettsDecember 2025$344,528NIC: EFFECTS OF PERIPHERAL INFLAMMATION ON MYELOID CELL FUNCTION IN ALZHEIMER'S DISEASE
Mass General Brigham IncorporatedSomerville, MassachusettsDecember 2025$327,501EXPANDING POSTMORTEM BRAIN RESOURCES FOR ALZHEIMER'S DISEASE IN DIVERSE POPULATIONS
DUKE UNIVERSITY SCHOOL OF MEDICINEDurham, North CarolinaDecember 2025$320,033UTILITY OF BLOOD BASED MARKERS FOR PREDICTING ARIA AND ITS COURSE IN MCI AND AD SUBJECTS UNDERGOING ROUTINE CLINICAL TREATMENT WITH AMYLOID-DIRECTED ANTIBODIES
Mass General Brigham IncorporatedSomerville, MassachusettsDecember 2025$300,000UNDERSTANDING HUMAN BRAIN RESILIENCE TO ALZHEIMER'S PATHOLOGY
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS & STROKEBethesda, MarylandDecember 2025$287,673BEE: HIGH-RESOLUTION MRI OF THE BRAIN BORDERS
Mass General Brigham IncorporatedSomerville, MassachusettsDecember 2025$287,500BEE: HUMAN 3D NEURO-VASCULAR INTERACTION AND MENINGEAL LYMPHATICS MODELS WITH APPLICATION TO ALZHEIMER'S DISEASE
NEW YORK UNIVERSITY SCHOOL OF MEDICINENew York, New YorkDecember 2025$287,500NIC: ASTROCYTE INFLAMMATORY CONTRIBUTIONS TO AD
REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGOLa Jolla, CaliforniaDecember 2025$287,500BEE: HOW DOES VASCULAR FATTY ACID METABOLISM REGULATE THE PATHOPHYSIOLOGY OF ALZHEIMER'S DISEASE?
REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGOLa Jolla, CaliforniaDecember 2025$287,500NIC: MECHANISMS MEDIATING MICROGLIA SENSING OF PERIPHERAL INFLAMMATION
STANFORD UNIVERSITYRedwood City, CaliforniaDecember 2025$287,500BAC: CHOROID PLEXUS AGING AND ALZHEIMER'S DISEASE
UNIVERSITY OF ROCHESTERRochester, New YorkDecember 2025$287,500BEE: DOES SLYM FAILURE COMPROMISE GLYMPHATIC CLEARANCE IN ALZHEIMER'S DISEASE?
WASHINGTON UNIVERSITY IN ST LOUISSt Louis, MissouriDecember 2025$287,500BAC: BRAIN REGION AND CELL-TYPE SPECIFIC AGING FROM ACCELERATED TO RESILIENT TRAJECTORIES
WASHINGTON UNIVERSITY IN ST LOUISSt Louis, MissouriDecember 2025$287,499BAC: ESTABLISHING ISOGENIC MODELS OF HUMAN NEURON AGING AND PATHWAYS RELEVANT FOR ALZHEIMER'S DISEASE
UNIVERSITY OF CALIFORNIA IRVINEIrvine, CaliforniaDecember 2025$287,490NIC: EXAMINING THE IMPACT OF PERIPHERALLY DERIVED HUMAN MACROPHAGES IN AD PATHOGENESIS
MASSACHUSETTS INSTITUTE OF TECHNOLOGYCambridge, MassachusettsDecember 2025$287,477BAC: INVESTIGATING LIPIDOMIC PERTURBATIONS IN THE CSF WITH AGE AND ALZHEIMER'S DISEASE PROGRESSION: TOWARD MECHANISTIC INSIGHTS AND ACCESSIBLE LIPID BIOMARKERS

Showing 25 of the 267 grants listed on its returns for the years ending December 2024 to December 2025. From Schedule I of its Form 990 returns for the years ending December 2024 to December 2025.